A B S T R A C T Experiments were done in normal rats to assess kidney, single nephron, and tubuloglomerular feedback responses during renin-angiotensin blockade with the converting enzyme inhibitor (CEI) SQ 20881 (E. R. Squibb & Sons, Princeton, N. Y.) (3 mg/kg, per h). Converting enzyme inhibition was documented by complete blockade of vascular responses to infusions of angiotensin I (600 ng/kg). Control plasma renin activity was 12.5+2.7 ng angiotensin I/ml per h (mean±SEM) and increased sevenfold with CEI (n = 7). There were parallel increases in glomerular filtration rate from 1.08±0.05 to 1.26±0.05 ml/min and renal blood flow from 6.7±0.4 to 7.5±0.5 ml/min. During CEI infusion absolute and fractional sodium excretion were increased 10-fold. Proximal tubule and peritubular capillary pressures were unchanged. Single nephron glomerular filtration rate (SNGFR) was measured from both proximal and distal tubule collections; SNGFR based only on distal collections was significantly increased by CEI. A significant difference was observed between SNGFR values measured from proximal and distal tubule sites (6.0±1.6 nl/min) and this difference remained unchanged after CEI administration. Slight decreases in fractional absorption were suggested at micropuncture sites beyond the late proximal tubule, whereas early distal tubule flow rate was augmented by CEI. Tubuloglomerular feedback activity was assessed by measuring changes in proximal tubule stop-flow pressure (SFP) or SNGFR in response to alterations in orthograde microperfusion rate from late proximal tubule sites. During control periods, SFP was decreased 11.2±0.4
INTRODUCTION
Although some of the systemic vascular and renal effects of angiotensin II appear clearly defined (1) (2) (3) , the intrarenal role of renin and the subsequent generation of angiotensin II in the regulation of glomerular filtration and tubular absorptive function remains a controversial issue. Several recent studies have examined the role of the renin-angiotensin system in the control of autoregulation of kidney hemodynamics (4-7), and although conflicting, these reports have failed to establish a pivotal role for the renin-angiotensin system in the mediation of autoregulatory adjustments in renal vascular resistance (4, 6, 7) . The possible influence of the renin-angiotensin system on the base-line control setting of renal hemodynamics has received somewhat greater support (3, 8, 9) . Other reports have suggested that angiotensin might also be one important determinant of renal tubular absorptive function (10) (11) (12) (13) .
The precise role of the renin-angiotensin system in the mediation of the distal tubule-glomerulus feedback system (tubuloglomerular feedback system) signals also remains unclear. It was initially suggested by Thurau and co-workers (14) that the renin-angiotensin system could be primarily responsible for the media-tion of signals from the macula densa cells of the distal nephron to the vascular elements responsible for the altered vascular resistance responses. Support for this concept has been equivocal; some studies have failed to confirm the essential role of the renin-angiotensin system in the mediation of feedback signals, whereas others have demonstrated that this system must participate, at least indirectly. A preliminary report by Stowe et al. (15) suggested that the tubuloglomerular feedback mechanism was at least partially inhibited by a blockade of angiotensin II or converting enzyme.
The purpose of these experiments was to examine further the possible role of the renin-angiotensin system in single nephron and kidney function in a normal rat preparation. Although not without limitations, one way to achieve this objective was to evaluate the effect of acute inhibition of converting enzyme using the competitive converting enzyme inhibitor (CEI)l derived from Bothrops jaracara venom, SQ 20881 (E. R. Squibb & Sons, Princeton, N. J.). Using this approach, the possible influence of intrarenal generation of angiotensin II on kidney and single nephron function might be determined.
In these experiments attention was focused on documenting the whole kidney clearance and hemodynamic responses after administration of CEI Chicago, Ill.) containing 0.15 meq Na+/g, and allowed free access to food and water. Anesthesia was induced with pentobarbital sodium (Nembutal, 50 mg/kg i.p.; Abbott Laboratories, North Chicago, Ill.), and maintained with small doses given intravensouly. Animals were prepared for micropuncture on a thermostatically controlled, heated table surface. A tracheostomy was performed, and three small polyethylene catheters were inserted into one external jugular vein for administration of anesthetic and infusion of solutions. An arterial cannula was inserted into the femoral artery. Arterial blood pressure was continuously measured with a transducer (model P-23 Dc, Statham Medical Instruments, Hato Ray, Puerto Rico) and recorded on a Grass recorder (model 5, Grass Instrument Co., Quincy, Mass.). The left kidney was isolated through a transverse, subcostal incision and placed in a small plastic cup; the ureter was catheterized; and the renal artery was isolated from adjacent structures. In 15 rats, an electromagnetic flow probe (model EP 401.5, Carolina Medical Electronics Inc., King, N. C., 1.5 mm circumference) was placed on the renal artery to allow direct and continuous measurement of renal blood flow. The flowmeter was calibrated in vitro with timed collection of whole blood, and verified in vivo using the para-aminohippuoric acid extraction technique as reported by Arendshorst et al. (4) . Mechanical zero flow was checked by momentarily occluding the renal artery in every experiment.
The kidney surface was superfused with warm (38°C) isotonic saline from the tip of a quartz rod light conductor.
An inulin solution (7.5 gIdl in 150 mM NaCl, Polyfructosan, Laevosan Gesellshaft, Linz, Austria) was administered as a priming dose of 1 ml followed by an infusion at 20 tdl/min (1.2 ml/h). Control period measurements were initiated 20 min later. Each control period consisted of two 30-min urine collections with femoral arterial blood samples obtained in heparinized tubes at the midpoint of each urine collection. Micropuncture protocols were conducted simultaneously with clearance collection periods. After the control period, a priming dose of 3 mg/kg of CEI in 0.5 ml of 155 mM/liter NaCl was given intravenously in 3 min. The priming dose was followed by an infusion of 3 mg/kg per h CEI in 155 mM/liter NaCl given at 10 ,ul/min (0.6 ml/h) and the inulin solution was changed to 15 g/dl given at 10 ,ul/min (0.6 ml/h). An additional 20 min were allotted to achieve a steady-state condition, and the protocol as described for the control period was repeated. In addition to the blood samples for polyfructosan determination taken during the clearance periods, femoral arterial blood samples (200 ul) were obtained from seven rats in each protocol at the end of the control period and 20 min after administration of CEI for the determination of plasma renin activity.
In six animals, tubular fluid samples for the determination of SNGFR were collected from paired distal and proximal superficial nephron sites before and after administration of CEI. Downstream tubular segments were identified visually with injections of small volumes (_5-10 nl) of artificial tubular fluid (ATF) stained with 0.25% fast green (Fast Green FCF, J. T. Baker Chemical Co., Phillipsburg, N. J.) into early proximal segments. The ATF solution contained 141 meq/liter sodium, 5 meq/liter potassium, 124 meq/liter chloride, 26 meq/liter bicarbonate, and 4 meq/liter calcium. The stained solution was injected through a 4-to 6-,tm Diam pipette placed in a random proximal tubule allowing identification of downstream, late proximal, and early distal superficial tubule segments of that nephron. After identification of downstream loops, a superficial segment of the early distal tubule of the same nephron was punctured with an oil-filled pipette of 6-to 8-,um Diam Germany) mounted on a micromanipulator, was inserted into a superficial loop of the same proximal tubule downstreamn from the wax block. The perfusion pump was calibrated in vivo and in vitro (17) with isotopic techniques; the design of the device allowed a built-in voltage generator to serve as the perfusion rate monitor. The perfusion pump pipette was inserted with the pump at zero flow, a maneuver that did not alter the continuously recorded proximal SFP. SFP was continuously recorded while perfusion rate was increased. When perfusion rate was altered, proximal SFP was recorded for a period of 3-5 min, and then the pump rate was changed to a new setting. The 3-to 5-min delay was always adequate for 15-to 30-sec pump lag time, the feedback response time, and the achievement of a plateau SFP recording. The actual feedback responses could occur within 15-20 s as was observed when the perfusion pipette was inserted into some tubules with the pump already set at a high perfusion rate. The feedback perfusion protocol consisted of SFP recordings at perfusion rates of 0, 5, 10, 15, 20, 30, and 40 nl/min altered in random sequence in each tubule. Zero perfusion rate SFP was reassessed after every second perfusion rate change and recovery to the initial SFP value was always +2 mm Hg. Each of the perfusion experiments consisted of measurement of SFP at least once at each perfusion rate in two or more different tubules in each period. In eight animals, the feedback responses were assessed in an initial control period and then reassessed after converting enzyme inhibition. In six additional animals the opposite sequence was used by administering CEI in an initial experimental period. Feedback responses were assessed and then the CEI infusion was terminated. After allowing 40 min for the decay of the enzyme inhibition, the responses of SFP to alterations in late proximal perfusion rate were reevaluated. This reversal of the sequence of the experimental protocol obviated possible system-atic, timedependent artifacts in the SFP-feedback perfuision responses.
A separate series of experiments in six animals examined the effects of a similar feedback-perfusion protocol on changes in SNGFR before and during CEI infusion. In these studies the nephron was identified and blocked with Nwax as described for the SFP-perfusioin studies. However, instead of continuously measuring proximlal tubule SFP, mutltiple timed collections of tubular fluid were obtained allowing determination of SNGFR at late proximal tubule microperfuision rates of 0, 10, and 30 nl/min. The responses of two or more different tubules were evaluated during each period.
Tubular fluid sample volulmes (nanoliters) were measuired in a precalibrated, constant-bore (quartz glass capillary wvith a slide comparator (Gaertner Scientific Co., Chicago, Ill.). A microfluorometric method (18) was used to determine tuibular fluid inulin concentration (TFin). Urine samples wvere collected under oil in small tared containers, and uirine volumes were determined gravimetrically. Femoral arterial blood samples (150 ,l) were collected in small polyethylene containers containing heparin (5 U U. S. Pharmacopeia). Inulin concentration in plasma (Pin) and urine (Uin) wvas measured with a semimicroanthronie technique (19) . Urine and plasma sodium concentrations (UNa and PNa) were determined by flame photometry. SNGFR, measured in nanoliters per minute, was computed by multiplying tubular fluid to plasma inulin ratios [(TF/P)in] by volume flow rates (nanoliters per minute). Kidney glomerular filtration rate (GFR) (measuired in milliliters per minute) was similarly computed from (U/P)in concentrations and urine flow rate (microliters per minute). The product of sodium concentration in urine (UNa) and urine flow rate (V) gave sodium excretion rate, and fractional sodium excretion (FENa, percentage) was calculated from (U/P)Na 100 divided by (U/P)in.
Blood samples (200 ,l) were obtained for plasma renin activity in iced tubes containing EDTA (disodiu-m edenate, 1 mg EDTA/ml of blood). The tubes were immediately centrifuged anid the plasmiia was decanted and frozen. Renin activity was determined in dtuplicate with 3-h incubation times by radioimmunoassay (Squibb Kit, E. R. Squibb & Sons.). The technique uised was a microadaptation of the method of Haber et al. (20) . Generation of angiotensin I was documented to be linear with time duiring the 3-h inctubation. Plasma renin is reported as nanograms of angiotensin I times milliliters plasma times houirs of incubation.
Values for each period for each animal were averaged, anid overall mean values were derived from mean values for each experiment. Observations from each period in each series of experiments were analyzed with a paired t test. Significance was accepted as a P value of <0.05.
RESULTS
The effectiveness of the converting enzyme blockade given in a dose of 3 mg/kg on the peripheral and renal vascular receptors is shown in Fig. 1 Fig. 3 . Arterial BP decreased slightly but significantly from 127±2 to 122±3 mm Hg (P < 0.05). RBF increased from 6.7±0.4 to 7.5±0.5 ml/min (P < 0.05). Similar to the clearance data, the increases in RBF after CEI were stable throughout both of the experimental clearance periods. Hematocrit decreased from 49±1 to 46±1 vol % (P < 0.01). Because (Table I) was small, the consistency of the observed increase in SNGFR, shown in Fig. 4 , allowed the achievement of statistical significance. As shown in Table I , the difference between SNGFR values measured at proximal and distal tubule sites was 6.0±+1.6 nl/min during the control period and was unchanged dturing the CEI infusion, 5 .7+1.8 nl/min. Mid-proximal volume flow rates and proximal (TF/P)i ratios were also unaltered. However, an increase in absolute volume delivery to the early distal tubule puncture site from 5.7+0.6 to 7.9±+1.0 nl/min was observed. The effects of the increases in volume flow rates at the early distal tubule collection sites were partially offset by slight decreases in mean (TF/P)i,, thus explaining the proportionally smaller increment in SNGFR based on collections from distal tubules. On the premise that SNGFRdiSt provides the more representative estimate of SNGFR (17, 21) , changes in proximal absorption were based on SNGFRdi,t and proximal (TF/P)in data. Absolute proximal absorption was 8.6±+1.3 ml/min in the control period and was not changed during infusion of CEI; fractional absorption was also unchanged from 31+4% (Table II) .
Although absolute volume delivery to the distal puncture site was increased after CEI infusion, absolute volume absorption by the loop and proximal tubule beyond the puncture site was unchanged after CEI, from 12.6±+1.2 to 12.8±+1.2 nl/min (P > 0.10). The fraction of the load delivered to the late proximal tubule and loop of Henle that was absorbed appeared to decrease from 69+3 to 61±3% but did not achieve statistical significance. The tubular fluid samples obtained at the early distal micropuncture sites revealed significantly increased absolute volume delivery, from 5.7±0.6 to 7.9±+1.0 nl/min and an increased fraction ofthe filtered volume from 0.19+0.02 to 0.27±0.03 delivered to those sites during infuision of CEI. The fraction of the filtered volume absorbed upstream from the early, accessible distal tubule puncture site was reduced from 0.81±0.02 to 0.73±0.03 althouigh the absolute volume absorbed was not altered by CEI. These absorptive alterations appear to be the result of slight increases in the rate of filtrate formation and subtle alterations in proximal tubule, loop of Henle, or early inaccessible distal tubule absorption rather than a specific effect on one tubule segment.
In 14 experiments, the sensitivity of the tubuloglomerular feedback mechanism was assessed by evaluating the responses of SFP to changes in distal nephron perfusion rate (Figs. 5 and 6, Table III) from late proximal tubule microperfusion sites. Fig. 5 shows the results of eight experiments in which the control observations were made before administration of CEI, and Fig. 6 shows the results of six experiments where the control observations were made after dissipation of the CEI given in the initial period. Be- (Table III) . The SFP responses from 0 to 15 nl/min and from 0 nl/min to all higher perfusion rates were significantly attenuated during CEI infusion.
The six experiments assessing the changes in SNGFR in response to alterations in late proximal tubule microperfusion rate before and during infusion of CEI are summarized in Table IV . During control conditions, proximal tubule volume flow and SNGFR both decreased slightly, but significantly, when perfusion into late proximal tubules was increased from 0 to 10 nl/min. In contrast, the deTubuloglomerular Feedback and Converting Enzyme Inhibition 1331 proportionally less than the increase in kidney GFR.
In agreement with previous studies (17, 21) , SNGFRP,OX was found to be consistently higher than SNGFR&i,t and this difference was maintained during CEI administration. As observed in a previous study examining the effects of plasma volume expansion (17) , the maintenance of the SNGFR difference based on paired collections from proximal and distal tubules might suggest an unaltered status of the tubuloglomerular feedback mechanism, the putative system responsible for these differences. However, when the maintenance of the SNGFRprOx-SNGFRdIst difference is considered in the context of the 40% increase of distal tubule fluid delivery observed during converting enzyme blockade, it would seem that some alteration in the distal tubule feedback mechanism must have occurred. Without some decrease in sensitivity of the feedback system, a greater distal volume delivery should decrease SNGFR as measured from distal tubule sites and result in differences in SNGFR between the two sites of greater magnitude. In fact, as noted above, SNGFRdist was actually increased.
The distal nephron microperfusion experiments demonstrated that, under control conditions, small but significant changes in SFP and SNGFR were observed as late proximal perfusion rate was altered in the range of 0 to 15 nl/min. These observations extend those of our earlier study (17) and, furthermore, provide an explanation for the observed differences in SNGFR based on proximal and distal tubule fluid collections. In some previous reports (22) The observations that the decrease in proximal tubule SFP or SNGFR at maximal perfusion rate was diminished support the concept that the sensitivity of the feedback mechanism is attenuated by CEI administration. Increases in volume delivery rates in the range of those observed for normal conditions (10) (11) (12) (13) (14) (15) nl/min) resulted in less change in SFP and SNGFR during infusion of CEI. Thus, the slight but significant renal vasodilation observed after administration of CEI can be explained on the basis of a decreased sensitivity of the feedback mechanism, allowing less than expected vascular resistance for the given higher distal tubule volume flow rate.
These results complement earlier studies reported by Schnermann and co-workers (24) and a recent report from our laboratory (17) , demonstrating that feedbackinduced responses in early proximal flow rate (24) or proximal tubule SFP (17) were decreased in states of acute or chronic extracellular fluid or plasma volume expansion. The attenuation of feedback activity after plasma volume expansion may be the result of reduced intrarenal renin activity or circulating angiotensin II. In the present experiments the attenuation oftubuloglomerular feedback activity would seem to be singularly the result of the CEI. Because some of the experiments were conducted in the reverse sequence, time-dependent decay of feedback activity was obviated. The most likely mechanism responsible for this depressed status of feedback sensitivity is intrarenal inhibition of the formation of angiotensin II or perhaps reduced circulating levels of angiotensin II. In this context, the data support the conclusion that converting enzyme in the in vivo rat kidney is inhibited with SQ 20881. This is at variance with a recent report that in in vitro preparations of renal tissue converting enzyme was not inhibited by SQ 20881 (25) . However, CEI is also known to potentiate the effects of bradykinin and possibly other active kinin species (26) (27) (28) and, therefore, the possibility of significant accumulation of such substances cannot be excluded. Although the role of possible kinin accumulation remains disputed (29, 30) , the preliminary report by Stowe et al. (15) wherein tubuloglomerular feedback activity was equally attenuated in protocols using CEI as compared with those in which the angiotensin II receptor antagonist Saralasin [Sar', Ile8] angiotensin II, Norwich-Eaton Pharmaceuticals, Norwich, N. Y.) was administered (15) , would support the possibility that the primary effect resulted from reduction in the renal action of the renin-angiotensin system on tubuloglomerular feedback sensitivity. Other, perhaps less likely, alternative mechanisms include alterations in renal nerve tone, circulating catecholamines, or some nonspecific vasodilator effect of CEI.
One of the principal reasons for conducting these experiments was to test the hypothesized role of the renin-angiotensin system in the mediation of the tubuloglomerular feedback responses as suggested by Thurau (14) . The failure to demonstrate complete inhibition of the feedback responses with CEI would seem to indicate that mediation of feedback signals does not depend singularly on the integrity of the renin-angiotensin system. However, as suggested in the past, it is possible that the demonstrably complete vascular blockade is not an adequate index of the integrity of the local, intrarenal renin-angiotensin system or mediation of the feedback responses. Nevertheless, the demonstration of vascular blockade seems to be the best physiological index available. To the extent that complete local blockade was achieved, the present results indicate that the renin-angiotensin cascade is one component of the system necessary for full expression of tubuloglomerular feedback activity.
It is also possible that angiotensin could modify baseline vascular resistance response relationships or could affect tubular absorptive function at the macula densa, in either case explaining the attenuated tubuloglomerular feedback responses to increases in distal delivery.
As mentioned, one finding of considerable interest was the marked natriuresis during CEI infusion. Recent studies have shown that low doses of angiotensin II may be antinatriuretic (13, 31) , and it is therefore attractive to associate the reduced angiotensin II generation and the natriuresis observed in these experiments. It should be clearly noted, however, that only a small fraction of the increment in a filtered load of sodium appeared in the urine during CEI infusion, documenting increased absolute tubular absorption during conditions of impaired angiotensin II generation.
Of interest is the speculative possibility that the absorptive alterations and the attenuated tubuloglomerular feedback activity might be more directly linked. Fractional absorptive function was depressed in tubule segments before and possibly involving the early distal tubule puncture site. It would seem plausible that the depressed absorptive capacity might also alter the sensor mechanism involved in initiation of the feedback signal such as has been demonstrated for the potent loop diuretics (32, 33) .
